MODIFICATION TO ABUSCREEN ONLINE FOR BENZOIDIAZEPINES

Enzyme Immunoassay, Benzodiazepine

ROCHE DIAGNOSTIC SYSTEMS, INC.

The following data is part of a premarket notification filed by Roche Diagnostic Systems, Inc. with the FDA for Modification To Abuscreen Online For Benzoidiazepines.

Pre-market Notification Details

Device IDK983702
510k NumberK983702
Device Name:MODIFICATION TO ABUSCREEN ONLINE FOR BENZOIDIAZEPINES
ClassificationEnzyme Immunoassay, Benzodiazepine
Applicant ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville,  NJ  08876 -3771
ContactRita Smith
CorrespondentRita Smith
ROCHE DIAGNOSTIC SYSTEMS, INC. BRANCHBURG TOWNSHIP 1080 U.S. HIGHWAY 202 Somerville,  NJ  08876 -3771
Product CodeJXM  
CFR Regulation Number862.3170 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1998-10-21
Decision Date1999-02-11
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.